abstract |
The present disclosure relates to a compound of formula (I), an anti-tumor use thereof, intermediate compounds thereof of formula (III) and formula (IV), and a use thereof. The compound of formula (I) has a degrading effect on a specific target protein, and is mainly composed of three parts: the first part is Small Molecules Binding Protein (SMBP); the second part is a linker unit (LIN); and the third part is a Ubiquitin Ligase Binding Moiety (LUM), wherein SMBP and LIN are covalently bound, and LIN is covalently bound to ULM. The compounds designed and synthesized by the present disclosure have a wide pharmacological activities, have a function of degrading specific proteins and/or inhibiting activities, and can be used for the treatment of associated tumor. |